Efficacy and Adverse Events of Bangpungtongseong-san (Bofutsusho-san ) and Bangkihwangki-tang(Boiogiot-tang ) by Oriental Obesity Pattern Identification on Obese Subjects: Randomized, Double Blind, Placebo-controlled Trial (비만 환자에서 한방 비만 변증에 따른 방풍통성산과 방기황기탕의 치료효과 및 부작용 비교: 무작위 배정, 이중 맹검, 위약-대조군 임상시험)

박정현; 이명종; Hojun Kim (김호준); 홍선우; 이동기; 유재욱; Choi Sun-mi (최선미); 문진석; 임지연; LEE JungBok (이정복)

Efficacy and Adverse Events of Bangpungtongseong-san (Bofutsusho-san ) and Bangkihwangki-tang(Boiogiot-tang ) by Oriental Obesity Pattern Identification on Obese Subjects: Randomized, Double Blind, Placebo-controlled Trial

Journal of Korean Medicine Rehabilitation
Abbr : JKMR
2011, 21(2), pp.265-278
Publisher : The Korean Academy Of Oriental Rehabilitation Medicine
Research Area : Medicine and Pharmacy > Korean Medicine

박정현 ¹, 이명종 ¹, Hojun Kim ¹, 홍선우 ¹, 이동기 ², 유재욱 ², Choi Sun-mi ³, 문진석 ⁴, 임지연 ¹, LEE JungBok ⁵

¹동국대학교
²성균관대학교
³한의학연구원
⁴한국한의학연구원
⁵고려대학교

Accredited

ABSTRACT

Objectives :This trial were conducted to evaluate the efficacy and adverse events of Bofutsusho-san(BTS) and Boiogiot-tang(BOT) by oriental obesity pattern identification on obese subjects, as compared to placebo. Methods :166 subjects(body mass index ≥ 25 kg/m2) were recruited and randomized to receive BT(n=55), FH(n=55) or placebo(n=56) for 8 weeks. Anthropometric factors, serum lipid, glucose, blood pressure(BP), pulse rate, resting metabolic rate and oriental obesity pattern identification questionnaire were measured at baseline and 8 weeks. Adverse events and safety outcome variables were also checked during trials. Results :The frequency of top-scored oriental obesity pattern was ordered by indigestion(食積) ＞ stagnation of the liver qi(肝鬱) ＞ yang deficiency(陽虛) ＞ spleen deficiency(脾虛) ＞ phlegm(痰飮) ＞ blood stasis(瘀血) in subjects. BTS group significantly decreased body weight, body mass index(BMI), waist circumference(WC), body fat mass, total cholesterol and HDL-cholesterol in stagnation of the liver qi(肝鬱) and WC in indigestion(食積). BOT group showed significant decrease of body weight, BMI, WC, and body fat mass in indigestion(食積) not in deficiency(虛症). Adverse events were reported most frequently in yang deficiency(陽虛) by BT group and stagnation of the liver qi(肝鬱) by BOT group. Conclusions :Bofu-tsusho-san was effective in treating obesity with stagnation of the liver qi(肝鬱). Obesity pattern identification could be a useful diagnostic tool predicting treatment effects and adverse events.

KEYWORDS

Bangpungtonseoung-san(Bofutsusho-san), Bangkihwangki-tang(Boiogiot-tang), Oriental obesity pattern identification

Citation status

* References for papers published after 2023 are currently being built.

[journal] AM Seifalian / 2010 / Obesity and arterial compliance alterations / Curr Vasc Pharmacol 8(2) : 155~168

[journal] TL Lenz / 2004 / Supplemental products used for weight loss / J Am Pharm Assoc 44(1) : 55~67

[journal] 이주아 / 2009 / Recent Topics of Clinical Trials in Obesity And Metabolic Study / 한방비만학회지 / 한방비만학회 9(1) : 15~22

[journal] PG Shekelle / 2003 / Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis / JAMA 289(12) : 1537~1545

[journal] 황미자 / 2008 / 2000년 이후 비만치료에 사용되는 처방 및 본초에 대한 문헌연구 / 대한한방비만학회지 7(1) : 39~54

[journal] 박정현 / 2009 / Systematic Review of Randomized Controlled Trials on Herbal Medicine for Treatment of Human Obesity / 한방재활의학과학회지 / 한방재활의학과학회 19(3) : 33~46

[confproc] 김동현 / 1999 / 장내세균에 의한 천연약물성분의 대사와 생리활성변화 / 동서의학 국제 심포지움 : 76~81

[journal] 김수진 / 2004 / 저열량 식이요법을 한 폐경 전 비만 여성의 휴식 대사량에 대한 마황과 오수유의 효과 / 대한한방비만학회지 4(1) : 45~54

[journal] 박정미 / 2005 / The Effects of Evodia Rutaecarpa and Ephedra Sinica on the Resting Metabolic Rate and Body Composition of Obese Women on a Low-Calorie Diet: A Double-blinded Randomized Controlled Clinical Trial / 대한한의학회지 / 대한한의학회 26(3) : 249~262

[journal] 이지은 / 2010 / Randomized, Double Blind, Placebo-Controlled Study of Bofu-tsusho-san on Obese Patients / 한방비만학회지 / 한방비만학회 10(1) : 1~16

[journal] 김정연 / 1993 / 비만에 대한 동서의학적 고찰 / 동의물리요법과학회지 : 299~314

[journal] 原桃仁 / 1987 / 國外醫學 / 中醫中藥分冊 3 : 21~

[journal] 김상만 / 1998 / 복부내장지방량을 가장 잘 표현할 수 있는 단순 비만지표는 / 대한비만학회지 7(2) : 157~168

[journal] 문진석 / 2007 / 한의사와 환자의 설문 응답을 통한 비만변증에 대한 주요 지표에 대한 연구 / 대한한방비만학회지 7(1) : 55~69

[book] 劉河間 / 1988 / 宣明論方, in 券十 문연각서고전서 중의학대계 / 여강출판사 : 768~

[book] 윤길영 / 1992 / 동의임상방제학 / 명보출판사 : 8~

[book] 이종대 / 2004 / 빈용 101 처방 / 정담 : 978~

[book] 張仲景 / 1985 / 金櫃要略方論 / 성보사 : 21~

[journal] 송용선 / 1991 / 방기황기탕 및 구기자가 비만백서의 체중에 미치는 영향 / 동의물리요법과학회지 1(1) : 25~43

[journal] 강병갑 / 2007 / 비만변증 설문지에 대한 신뢰도 분석 / 한국한의학연구원 논문집 13(1) : 109~114

[journal] 강경원 / 2008 / The Discrimination Model for the Pattern Identification Diagnosis of Overweight Patients / 한국한의학연구원논문집 / 한국한의학연구원 14(2) : 41~46

[journal] 황미자 / 2008 / Analysis of Oriental Obesity Pattern Identification Questionnaire on Overweight and Obese Korean Adult Women / 한방비만학회지 / 한방비만학회 8(2) : 63~72

[journal] 이종립 / 2001 / 방기황기탕의 혈위 주입이 비만에 미치는 영향 / 한방재활의학과학회지 11(1) : 297~315

[journal] 신대희 / 2008 / Clinical study of Bangpoongtongsungsan on body weight change in subjects with obesity / 대한한의학 방제학회지 / 대한한의학방제학회 16(2) : 133~144

[journal] 이재훈 / 2009 / A Study on the Acute Toxicity of Bangpungtongsung-san(Fangfengtongsheng-San) in Mice / 한방비만학회지 / 한방비만학회 9(1) : 71~78

[journal] 이지혜 / 2009 / A Study on the Acute Toxicity of Fermented Bangpungtongsung-san(Fangfengtongsheng-san) Extract in ICR Mice / 한방비만학회지 / 한방비만학회 9(2) : 11~19

[journal] Shimada T / 2008 / Preventive effects of Bofutsushosan on obesity and various metabolic disorders / Biol Pharm Bull 31(7) : 1362~1367

[journal] Hioki C / 2004 / Efficacy of bofutsusho-san, an oriental herbal medicine, in obese Japanese women with impaired glucose tolerance / Clin Exp Pharmacol Physiol 31(9) : 614~619

KJCKorea
Journal Central

Journal of Korean Medicine Rehabilitation 2023 KCI Impact Factor : 0.6